Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001438133-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-11 | 2025-03-07 | TNDM | Kyrillos Jean-Claude | EVP, COO | P - Purchase | $18.12 | +10.5K | 10.5K | New | +$190.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | P | A | 10,538 | $18.12 | 10,538 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $18.115 to $18.13 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |